Skip to main content
Novacyt S.A. (EPA:ALNOV)
France flag France · Delayed Price · Currency is EUR
0.386
+0.001 (0.26%)
Mar 9, 2026, 5:35 PM CET

Novacyt Revenue

Novacyt had revenue of 9.79M GBP in the half year ending June 30, 2025, with 193.29% growth. This brings the company's revenue in the last twelve months to 19.45M, up 39.55% year-over-year. In the year 2024, Novacyt had annual revenue of 19.63M with 84.82% growth.

Revenue (ttm)
19.45M GBP
Revenue Growth
+39.55%
P/S Ratio
1.19
Revenue / Employee
83.12K GBP
Employees
234
Market Cap
27.11M EUR

Revenue Chart

* This company reports financials in GBP.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202419.63M9.01M84.82%
Dec 31, 202310.62M-10.42M-49.52%
Dec 31, 202221.04M-71.56M-77.28%
Dec 31, 202192.60M-184.60M-66.59%
Dec 31, 2020277.20M265.74M2,317.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Theraclion 1.87M
Implanet 11.10M
Ikonisys 1.47M
Diagnostic Medical Systems 49.47M
Mauna Kea Technologies 8.18M
Biosynex 97.95M
SpineGuard 4.32M
Bluelinea Société Anonyme 11.68M
Revenue Rankings

Novacyt News

More News